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Abstract 
Neuro-glial signaling pathways are known to influence complex behavior, including fear 
learning processes that may contribute to the development of psychopathological conditions like 
Post-Traumatic Stress Disorder (PTSD). Recent findings from our laboratory have demonstrated 
a contribution of proinflammatory cytokine expression in the dorsal hippocampus to such fear 
learning processes. Astrocytes are thought to be the primary cellular source of this expression, 
but technological limitations have thus far prevented researchers from selectively isolating the 
precise contribution of astrocytes to this expression. We utilized Designer Receptors Exclusively 
Activated by Design Drugs (DREADDs) to examine the role of astrocyte signaling in the dorsal 
hippocampus in fear learning. We expressed a Gq-coupled DREADD virus under an astrocyte 
specific promoter such we could test whether activating Gq signaling in astrocytes prior to fear 
conditioning influenced contextual fear learning. We found that activating Gq-signaling in 
hippocampal astrocytes enhanced contextual fear learning. This finding suggests that 
gliotransmission driven by astrocytes in the dorsal hippocampus directly enhances fear learning 
and supports the feasibility of employing glial-expressing DREADD technology to examine 
astrocyte function in complex behavior.  
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Astrocyte Modulation of Fear Learning 
 Astrocytes are best known as support structures for neurons, but, in recent decades, 
findings have revealed them to be capable of communication with neurons through the release of 
gliotransmitters such as glutamate, ATP, or cytokines (Lee et al., 1993; Meeuwsen et al., 2003). 
These neuro-glial signaling pathways can modulate a wide range of complex behavior. For 
example, under basal conditions, neural cytokines are known to be involved in processes such as 
normal fear conditioning and anxiety behavior (Koo & Duman, 2009). Further, we recently 
demonstrated that neural cytokine signaling is a critical component in the development of stress-
enhanced fear learning (SEFL), an animal model of Post-Traumatic Stress Disorder (PTSD) 
(Jones et al., 2015). Astrocytes are thought to be the primary source of cytokine expression in 
these processes because, though many cell types are capable of releasing neural cytokines, it has 
been demonstrated that, following acute stress, increased cytokine reactivity is co-localized with 
astroglia (Sugama et al., 2011). Such findings suggest that astrocyte signaling is crucial to these 
processes, but technological limitations have thus far prevented researchers from selectively 
isolating the activity of specific cell types in conjunction with behavioral measures in order to 
isolate the precise contribution of cell-type specific signaling in complex behaviors like fear 
learning. Recently, however, the development of Designer Receptors Exclusively Activated by 
Designer Drugs (DREADDs) has allowed researchers to utilize pharmacogenetic methods to 
manipulate isolated cell populations in vivo. The current project takes advantage of this 
technology to explore the role of glial cells, specifically astrocytes, in fear learning as it relates to 
the development of PTSD.   
Proinflammatory cytokines are important gliotransmitters that are secreted from 
astrocytes and can directly alter central signaling (Lee et al., 1993; Meeuwsen et al., 2003). 
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Under basal conditions, the regular secretion of proinflammatory cytokines such as interleukin-
1β (IL-1β) and tumor necrosis factor-α (TNF-α) is important for the facilitation of learning, 
memory, and neural plasticity (for a review, see Yirmiya et. al., 2010). For example, during LTP 
induction in the hippocampus, 1L-1β gene expression increases rapidly to low levels (Schneider 
et al., 1998). This low-level cytokine expression is necessary for the maintenance of LTP, as, 
when IL-1 signaling is blocked through transgenic manipulations or administration of IL-1 
receptor antagonist (IL-1ra), LTP induction is prevented (Schneider et al., 1998).  
Although low levels of proinflammatory cytokines are beneficial and necessary for 
learning and hippocampus-dependent memory, it is apparent that deviation from these basal 
levels results in the impairment of these functions. For example, TNF-α appears to facilitate 
proliferation of neurons at low levels, while at high levels it can cause neuron death (Bernardino 
et al., 2008), and IL-1β has been shown to impair hippocampal-dependent memory when 
administered immediately after learning (Gonzalez et al., 2009). These observations have lent 
credence to the suggestion that proinflammatory cytokines such as IL-1β and TNF-α follow an 
inverted U-shaped pattern of activation for contributions to hippocampal memory, such that 
extremely low or high levels of expression result in impairment of hippocampal-dependent 
memory while moderate levels of expression facilitate this type of memory (Goshen et al., 2007).  
In support of this inverted U-shaped pattern of activation for proinflammatory cytokines, 
preclinical rodent models have consistently demonstrated that proinflammatory cytokine gene 
expression increases dramatically in the hippocampus following contextual fear learning 
(Yirmiya et. al, 2010). Critically, this expression does not increase immediately, but rather 
exhibits a temporal delay of about 24 hours (Goshen et al., 2007), which suggests that increased 
IL-1β gene expression is a crucial component of contextual fear learning that occurs as a 
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consequence of exposure to a stressor. In support of this idea, Goshen et al. (2007) showed that 
IL-1ra, which prevents IL-1β from binding to IL-1 receptors, prevents contextual fear learning. It 
is important to note that numerous studies have isolated the impact of proinflammatory cytokines 
on memory to hippocampus-dependent memory processes (for a review, see Yirmiya et. al, 
2010). These studies demonstrate that an elevation in hippocampal levels of proinflammatory 
cytokines results in a reduction in contextual memory, a form of memory dependent upon the 
hippocampus, but does not have an effect on non-contextual memory, which is hippocampal-
independent (Gonzalez et al., 2009). 
The detrimental effect of elevated proinflammatory cytokine levels has particular 
relevance to the study of anxiety disorders such as Post-Traumatic Stress Disorder (PTSD). 
PTSD is a clinical condition that may develop after exposure to a traumatic event. The hallmark 
symptoms of PTSD include intrusions, or flashbacks in the form of dreams or vivid memories, 
avoidance, meaning both avoidance of reminders of the experienced trauma as well as 
withdrawal from activities and loved ones, and hyperarousal, or a heightened sensitivity to 
potentially stressful experiences (American Psychiatric Association, 2013). This third symptom, 
also referred to as hyperreactivity, describes situations in which fear is inappropriately regulated 
such that, after exposure to a severe stressor, subsequent exposure to a mild stressor evokes a 
severe response akin to a re-exposure to the severe stressor. This response can be described as a 
generalization of the context of the original trauma to a distinct context in which the severity of 
the patient’s response is inappropriate. As such, enhanced fear learning that is resistant to 
extinction can be thought of as an important component of PTSD.  
Because PTSD cannot be studied experimentally, animal models of the disorder are 
invaluable for understanding the neuroplastic changes that occur following exposure to a severe 
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stressor that may lead to the development of PTSD. Stress-enhanced fear learning (SEFL) is an 
animal model of PTSD that excellently captures the hyperreactivity to future fear learning events 
that occurs in PTSD (Rau, DeCola, & Fanselow, 2005). Work in our laboratory with this model 
has demonstrated the involvement of proinflammatory cytokines in this process. For example, in 
the Lysle laboratory, we recently observed a time-dependent increase in IL-1β expression in the 
dorsal hippocampus following exposure to a severe stressor, and showed that central 
administration of IL-1ra after exposure to this stressor prevents enhanced fear learning (Jones et 
al., 2015). These findings are consistent with clinical evidence that demonstrates that elevated 
serum levels of proinflammatory cytokines are often linked with PTSD (for a review, see Gill et 
al., 2009). As such, these findings provide further evidence that neuroimmune signaling in the 
dorsal hippocampus contributes to altered fear learning in PTSD, though the exact mechanism of 
this action and the cellular source of this proinflammatory cytokine expression remain unknown. 
The overall goal of the present study was to elucidate the precise contribution of 
hippocampal astrocytes to the memory impairment caused by the brain’s immune response to 
stress by isolating and manipulating the activation of Gq signaling in hippocampal astrocytes. 
This was achieved through the transduction of an adeno-associated virus (AAV) in the dorsal 
hippocampus to express Gq-coupled Designer Receptors Exclusively Activated by Designer 
Drugs (Gq-DREADDs) under the glial fibrillary acidic protein (GFAP) promoter. DREADDs are 
pharmacogenetically modified G protein-coupled receptors (GPCRs) that respond specifically to 
clozapine-N-oxide (CNO) (Armbruster et al., 2007). As such, DREADD-expressing astrocytes 
are unaffected by endogenous activity, meaning that Gq signaling can be selectively activated in 
astrocytes within the dorsal hippocampus through intraperitoneal (i.p.) administration of CNO. 
Importantly, the effects of CNO persist only temporarily, meaning that targeted cells are 
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activated for a short span of time, allowing for much flexibility in experimental procedure 
(Armbruster et al., 2007). Thus, we used glial-expressing DREADD technology to test whether 
activating Gq signaling in astrocytes for six hours prior to a traditional foot shock fear 
conditioning paradigm would alter fear learning. Given that our previous studies showed that 
stress-induced IL-1β signaling was a critical component to the development of enhanced fear 
learning, we predicted that increased neuroinflammatory activity in the dorsal hippocampus 
would render animals hypersensitive to fear learning events. Thus, we predicted that activating a 
Gq-signaling pathway in astrocytes prior to foot shock conditioning would enhance fear learning. 
Method 
Animals 
 Male Sprague–Dawley rats (250–400 g in weight, Charles-River Laboratories, Raleigh, 
NC) were housed individually in a colony room under a reversed day–night (12-hour) cycle. The 
rats were allowed ad libitum access to food and water throughout the experiment. During a four-
week acclimation period prior to experimentation, the rats were handled regularly. All 
manipulations were initiated 1 hour into the dark phase of the day–night cycle. All procedures 
were conducted in accordance with and approval by the UNC Institutional Animal Care and Use 
Committee (IACUC). 
Surgical Procedures 
 Stereotaxic virus infusion. Animals were surgically infused with the viral vector, 
rAAV5/GFAP-HA-hm3D-IRES-mCitrine, purchased from the UNC Gene Therapy Center, 
Chapel Hill, NC. Animals were anesthetized with a 1.0 mg/kg intraperitoneal injection of 9:1 
(vol:vol) ketamine hydrochloride (100 mg/ml) mixed with xylazine (100 mg/ml) and placed in a 
stereotaxic apparatus. Two small holes were opened in the skull and an injection micropipette 
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was used to micro-inject 0.7 µl of the viral vector. Injectors were directed bilaterally at the dorsal 
hippocampus (AP -3.4 mm, ML ±3.1, DV -2.15 mm, 15° relative to bregma; infusion speed 23 
nl/min; Nanoliter 2000 Injector, WPI). Purified virus was obtained pre-dialyzed (350mM NaCl, 
5% D-sorbitol in phosphate buffered saline) and microinjected at 4 x 1012 particles/ml, 0.7 µl per 
hemisphere over 7 minutes. Injectors were left in place for 15 minutes to allow for diffusion and 
to avoid backflow of the virus to the surface. Animals were given three weeks for post-operative 
recovery, after which they were exposed to additional procedures before beginning behavioral 
testing. Upon completion of the experiment, correct virus expression was verified and animals 
with incorrect virus expression were dropped from the analysis.  
Behavioral Procedures 
Fear conditioning was conducted in a standard rodent chamber (BRS/LVE, Laurel, MD; 
26.7 × 24.8 × 30.7) housed in a metal sound-attenuating cubicle (BRS/LVE, Laurel, MD) in a 
room separate from the animal colony. The chamber had a 16 bar grid floor design (.48 cm in 
diameter spaced 1.8 cm apart), smooth metal side walls, and clear plastic front and rear walls. 
Cedar bedding and vanilla extract were used in the chambers to create a distinct environment 
from the home cages. Grid floors were wired to a BRS/LVE shock generator (SG903) and 
scrambler (SC922). The interior lights were kept on. The grid floor was wired to a Med 
Associates shock generator and scrambler (ENV-414). Behavior was recorded using a video 
recording system (Sony Video Camera Model HDR-CX150) directed at the clear front wall of 
the chamber.  
The experimental design is summarized in Table 1. Animals (N = 21) were randomly 
assigned to a drug treatment (CNO or saline vehicle) and to a shock treatment (foot shock or no 
foot shock). On the treatment day, animals were administered 3.0 mg/kg of CNO or saline 
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vehicle (i.p.) at three time points prior to conditioning: 4.5 hours, 2.5 hours, and 30 minutes. 
After the final CNO administration, animals were placed in the standard rodent chamber. Each 
animal was placed in the conditioning chamber for 3 min 44 s and received either 5 scrambled 
foot shocks (2 mA, 1 s, 30 s variable interval schedule) or no shocks. Animals were then 
removed from the conditioning chamber and returned to their home cages. Twenty-four hours 
later, behavioral testing began. Animals were tested in the conditioning chamber for the 
assessment of freezing behavior, a behavioral quantification of learned fear, during an 8 min 32 s 
session (no shocks administered). Freezing behavior was measured as the time spent immobile, 
except for movement necessary for respiration (Rau, DeCola & Fanselow, 2005). The complete 
session recording was analyzed by raters blind to the treatment condition. Following the 
completion of the above behavioral procedures, animals were sacrificed via transcardial 
perfusion and brains were extracted for immunohistochemical analysis of virus expression. 
Immunohistochemical Analysis 
Animals were deeply anesthetized with 9:1 (vol:vol) ketamine hydrochloride (100 
mg/ml) mixed with xylazine (100 mg/ml) and transcardially perfused with cold phosphate buffer 
(PB; pH = 7.4) followed by 4% paraformaldehyde in 0.1 M PB. Brains were placed in 30% 
sucrose for cryoprotection and sliced into 40 µm sections. To ensure that the virus was expressed 
in the dorsal hippocampus and only in astrocytes, we conducted fluorescence 
immunohistochemical staining for virus expression (using an antibody against the HA-tag in the 
viral construct we utilized) and GFAP, an astrocyte marker. Tissue sections were washed for 15 
minutes with 0.1 M PB, and pre-incubated for 60 minutes in 0.4% TritonX-100 in 0.1M PB. 
Sections were then incubated for 60 minutes with 3% normal goat serum and 0.4% Triton X-100 
in 0.1 M PB. Sections were incubated overnight with rabbit anti-HA (1:500; Cell Signaling, 
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Danvers, Ma) in 0.1 M PB with 3% normal goat serum and 0.4% TritonX-100. The following 
day, sections were washed three times in 0.1 M PB and incubated overnight with mouse anti-
GFAP (1:1000, Thermo-Fisher Scientific, Waltham, Ma). Alexafluor488-conjugated and 
Alexfluor-594-conjugated secondary antibodies (1:1000, Life Technologies, Grand Island, NY) 
were used for visualization. Tissue sections labeled with only secondary antibodies were used as 
secondary controls to ensure specificity of our primary antibodies. Sections were mounted onto 
SuperFrost Plus slides (Fisher Scientific, Pittsburgh, PA) using Vectashield with DAPI hardset 
mounting medium (Vector Laboratories, Burlingame, CA).  
Color images were captured through a digital camera (Roper Scientific), mounted on an 
optical microscope (BX-51, Olympus). Images captured were between -2.76 mm and -4.2 mm 
relative to bregma (Paxinos and Watson, 1998). 
Statistical Analyses 
The effect of drug treatment (CNO or saline vehicle) and shock treatment (foot shock or 
no foot shock) on freezing behavior during the test day was analyzed for statistical significance 
using a standard 2 × 2 analysis of variance (ANOVA). Percent freezing during the test session 
was analyzed with drug treatment (CNO or saline vehicle) and shock treatment (foot shock or no 
foot shock) as between-subject variables. For all experiments, the significance level was set at 
.05. Significant interactions were examined using LSD post-hoc comparisons. 
Results 
Gq- DREADD was expressed in astrocytes in the dorsal hippocampus 
 For the final data analysis, only data from animals that expressed the Gq-DREADD virus 
in hippocampal astrocytes was included. We observed dense virus expression that was co-
localized with GFAP in the dorsal hippocampus of rats infused with the virus in 16 rats. See 
ASTROCYTE MODULATION OF FEAR LEARNING 12 
Figure 1. These data provide evidence that the DREADD virus was expressed in astrocytes in the 
dorsal hippocampus. Unfortunately, we observed neuronal expression of the virus in a significant 
portion of rats infused with the virus. Thus, these animals were dropped from our analysis to 
avoid confounding effects that may have resulted from activation of Gq signaling in neurons 
during our behavioral paradigm.  
CNO enhanced fear learning  
 A 2 x 2 ANOVA revealed a significant main effect of drug treatment, F(1, 17) = 5.37, p 
< .05 and a significant main effect of foot shock treatment, F(1,17) = 6.047, p < 0.05. LSD post 
hoc comparisons showed that animals that received CNO and were exposed to moderate foot 
shock exhibited significantly more freezing behavior (M = 76.33%, SD = 23.24) than animals 
that received saline vehicle and were exposed to moderate foot shock (M = 39.11%, SD = 25.77), 
p < .05. See Figure 2. Thus, these results show that activation of Gq signaling in astrocytes in the 
dorsal hippocampus prior to exposure to a moderate foot shock enhanced contextual fear 
learning. 
Discussion 
The goal of the current study was to apply new pharmacogenetic technology to a 
traditional fear-conditioning paradigm in order to explore the role of astrocytes in fear learning. 
Recent pharmacogentic developments allowed us to selectively activate Gq signaling in dorsal 
hippocampal astrocytes in vivo. We predicted that activating Gq signaling in astrocytes for four 
hours prior to fear conditioning would enhance fear learning. Thus, we expected to find that Gq-
DREADD-expressing animals that received CNO would exhibit an exacerbated behavioral fear 
response following exposure to a moderate stressor. This hypothesis was supported, and the 
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current findings suggest that activating Gq signaling in astrocytes in the dorsal hippocampus 
renders animals more susceptible to enhanced fear learning.  
The current findings are of particular relevance to the study of PTSD, a disorder in which 
enhanced fear learning becomes maladaptive. Clinical evidence demonstrates that elevated 
serum levels of proinflammatory cytokines are often linked with PTSD (Spivak et al., 1997; Gill 
et al., 2009). As such, it may be that neuroinflammation caused by astrocyte immune signaling 
contributes to the detrimental effect that severe stress and psychological trauma can have on the 
brain, leading to the development of PTSD. This hypothesis is also supported by previously 
published preclinical data from our laboratory that suggests that neuroinflammation in the dorsal 
hippocampus that is induced following an initial severe stressor is a critical component of stress-
enhanced fear learning (Jones et al., 2015). The current data are consistent with this hypothesis, 
suggesting that excess inflammatory activity induced by astrocyte signaling in the dorsal 
hippocampus prior to fear conditioning hypersensitizes the animal to future fear learning 
experiences. 
The results of the current study provide early support for this hypothesis and demonstrate 
the potential value of DREADD technology to future studies of fear learning. However, it is 
important to note that one limitation of the current study was our sample size. Virus expression 
in non-astrocyte cells in some animals forced us to exclude data from a large portion of our 
sample. Future studies should optimize glial-expressing DREADD technology to eliminate virus 
expression in non-astrocyte cells and replicate the current findings. Still, the current study is the 
first to employ glial-expressing DREADDs in a fear learning paradigm and our findings suggest 
that DREADD technology’s ability to manipulate isolated cell populations at high levels of 
spatial and temporal specificity could make it a powerful tool in future studies of fear learning.  
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Future studies may apply this technology in the effort to better understand and 
contextualize the implications of the present findings regarding the Gq signaling of dorsal 
hippocampal astrocytes as they relate to PTSD. Specifically, though the current study suggests 
that the selective activation of Gq-DREADD signaling in astrocytes in the dorsal hippocampus 
successfully enhances fear learning, we did not examine physiological components of learning in 
the hippocampus. As such, it may be prudent to utilize DREADD technology in studies of other 
memory processes that may also involve astrocyte signaling. For example, proinflammatory 
cytokines like IL-1β have been shown to facilitate Long-Term Potentiation (LTP) (Lynch, 2004). 
To this end, an application of DREADD technology to established animal models of memory 
could prove invaluable to identifying the specific role of astrocytes in this context. Further, 
because the dorsal hippocampus does not function in isolation, using Gq-DREADD technology 
to selectively activate Gq signaling in astrocytes in other areas of the brain involved in fear 
learning, such as the basolateral amygdala or perirhinal cortex (Kim et al., 2011) would allow for 
a better understanding of how this network functions in response to severe stressors. 
Additionally, though the current study approached fear learning by targeting Gq signaling 
in astrocytes, an examination of alternate astrocyte signaling pathways may provide further 
insights into how astrocyte signaling contributes to the development of PTSD. PTSD imposes a 
severe fiscal and emotional cost on society and a prophylactic pharmaceutical treatment remains 
a highly sought after clinical tool. Recent evidence from our laboratory has suggested that anti-
inflammatory manipulations in the dorsal hippocampus following trauma can prevent the 
development of SEFL. The activation of Gi signaling in astrocytes is known to counteract 
glutamate-evoked Ca2+ elevations in astrocytes, which we hypothesize may directly alter 
cytokine release (Block et al., 2013). If activating Gi signaling in hippocampal astrocytes 
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following trauma can prevent SEFL in animals, these findings would provide a new target for the 
development of such preventative treatments. Viral constructs for Gi-coupled DREADD 
receptors, which selectively activate Gi signaling in astrocytes, could be utilized in both 
traditional fear learning paradigms and animal models of PTSD, such as SEFL, in order to assess 
the involvement of Gi astrocyte signaling in fear learning. Gi-coupled GPCR signaling in 
astrocytes counteracts intracellular Ca2+ release evoked by glutamate, which we hypothesize 
could directly attenuate the release of proinflammatory cytokines known to be critical to stress-
enhanced fear learning. Empirical confirmation of this hypothesis would provide further 
evidence for a critical role of astrocyte signaling in fear learning processes.  
In sum, the current study provides the first evidence that astrocyte function is important 
in fear learning. Our data demonstrate that activating Gq signaling in hippocampal astrocytes 
prior to fear conditioning enhances contextual fear learning. Further, these data support the 
feasibility of applying glial-DREADD technology in vivo to study the importance of astrocyte 
function in complex behavior. 
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Table 1 
Experimental design 
 N Drug treatment Shock treatment Test day 
Group 1 5 CNO (3 mg/kg) 4.5 hr, 2.5 hr, 
30 min before conditioning 
4 min with 5 scrambled 
shocks (2 mA, 1 s)  
Conditioning 
chamber 8 min 32 s 
Group 2 5 Saline vehicle (3 mg/kg) 
before conditioning 
4 min with 5 scrambled 
shocks (2 mA, 1 s) 
Conditioning 
chamber 8 min 32 s 
Group 3 4 CNO (3 mg/kg) 4.5 hr, 2.5 hr, 
30 min before conditioning 
3 min 44 s with no shock Conditioning 
chamber 8 min 32 s 
Group 4 7 Saline vehicle (3 mg/kg) 
before conditioning 
3 min 44 s with no shock Conditioning 
chamber 8 min 32 s 
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Figure 1. Gq-DREADD virus expression. Top panel shows Gq-DREADD expression in the 
dorsal hippocampus. Anti-Ha antibody (Cell signaling, Danvers, MA) is shown in green, 10x. 
Bottom panel shows co-localization of the Gq-DREADD virus (green) with GFAP (red), 
showing that virus is expressed in astrocytes. 
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Figure 2. Repeated CNO administration (3 mg/kg, i.p. 4.5, 2.5, 0.5 hours prior to fear 
conditioning) enhanced fear learning. Animals that received CNO prior to foot shock exhibited 
exacerbated freezing behavior, * greater than Shock/Veh (vehicle), p < .05. 
 
